Alkaline Buffered Liquid Neutralizes Chemotherapy Acid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chemotherapy side effects, such as nausea, hair loss, and difficulty breathing, are severe and often require additional medications that have their own side effects, complicating treatment and patient health.
Innovation Solution
A buffered aqueous liquid with a pH of 10 to 11.5, composed of sodium bicarbonate, sodium carbonate, and trisodium phosphate, is administered to patients to neutralize acid and promote alkalinity, reducing chemotherapy side effects by maintaining a healthy pH balance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If additional medications are administered to treat chemotherapy side effects, then the side effects are managed, but the patient is subjected to more negative side effects from the additional drugs
Solution Approach 1:
The patent converts the harmful acidic environment created by chemotherapy into a beneficial condition by administering alkaline substances (pH 10-11.5) that neutralize the acid. This transforms the harmful acidic byproducts of chemotherapy into a balanced pH environment, reducing side effects without requiring additional medications that would introduce new harmful factors.
Solution Approach 2:
The patent changes the pH parameter of the patient's body environment from acidic (harmful) to alkaline (beneficial). By administering compositions with pH 10-11.5, the patent shifts the body's pH balance to reduce chemotherapy side effects, addressing the root cause rather than treating symptoms with more drugs.
2Object-affected harmful factors
If multiple types of drugs are administered to address different side effects, then comprehensive symptom management is achieved, but the complexity of treatment increases
Solution Approach 1:
The patent employs a universal alkaline composition (pH 10-11.5) that addresses multiple chemotherapy side effects simultaneously through a single mechanism (pH neutralization). This multi-functional approach replaces the need for multiple specialized medications, each targeting specific side effects, thereby simplifying the overall treatment regimen while maintaining comprehensive symptom management.
3Reliability
If the body's pH is maintained at 7.4, then the body's resistance to harm is enhanced, but the ability to neutralize acidic byproducts of chemotherapy is reduced
Solution Approach 1:
The patent applies preliminary action by administering alkaline compositions (pH 10-11.5) before or during chemotherapy treatment to preemptively neutralize acidic byproducts. This preliminary alkaline intervention prevents excessive acidification, allowing the body to maintain its optimal pH 7.4 resistance state while still effectively managing chemotherapy-induced acidity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces chemotherapy side effects, improving patient health by maintaining a pH of 7.4, which enhances the body's resistance to harm and reduces adverse reactions to medications.
Implementation Method 1
A buffered aqueous liquid with a pH of 10 to 11.5, composed of sodium bicarbonate, sodium carbonate, and trisodium phosphate, is administered to patients to neutralize acid and promote alkalinity
Data Source
AI summary
This disclosure relates to treatments for reducing the side effects associated with treatment of a medication or drug, such as a chemotherapy medication, being experienced by a patient. This may be accomplished by administering to a patient taking the medication, a buffered aqueous liquid having a pH of about 10 to about 11.5, wherein the buffered aqueous liquid comprises sodium bicarbonate, sodium carbonate, and trisodium phosphate.